Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
3.570
-0.200 (-5.31%)
At close: Apr 28, 2026, 4:00 PM EDT
3.552
-0.018 (-0.51%)
After-hours: Apr 28, 2026, 4:19 PM EDT
Artelo Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.98 | 4.12 | 4.23 | 5.96 | 6.29 | |
| Research & Development | 5.42 | 5.99 | 5.7 | 4.32 | 5.83 | |
| Operating Expenses | 11.4 | 10.11 | 9.93 | 10.29 | 12.13 | |
| Operating Income | -11.4 | -10.11 | -9.93 | -10.29 | -12.13 | |
| Interest Expense | -0.28 | - | - | -0.01 | - | |
| Interest & Investment Income | - | - | - | 0 | 0 | |
| Other Non Operating Income (Expenses) | -0.06 | - | - | - | - | |
| EBT Excluding Unusual Items | -11.74 | -10.11 | -9.93 | -10.29 | -12.12 | |
| Gain (Loss) on Sale of Investments | 0.02 | 0.28 | 0.64 | 0.21 | 0.02 | |
| Other Unusual Items | -1.16 | - | - | - | - | |
| Pretax Income | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Net Income | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Net Income to Common | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 91.62% | 8.85% | 4.48% | 27.04% | 79.12% | |
| EPS (Basic) | -37.55 | -54.89 | -56.49 | -64.06 | -97.71 | |
| EPS (Diluted) | -37.55 | -54.89 | -56.49 | -64.06 | -97.74 | |
| Free Cash Flow | -8.52 | -8.35 | -8.21 | -8.01 | -8 | |
| Free Cash Flow Per Share | -24.84 | -46.65 | -49.91 | -50.88 | -64.58 | |
| EBIT | -11.4 | -10.11 | -9.93 | -10.29 | -12.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.